Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Targeting MAPK signalling: Prometheus' fire or Pandora's box?

Simone Boldt1, Walter Kolch

  • 1Beatson Institute for Cancer Research, Garscube Estate, Switchback Road, Bearsden Glasgow G61 1BD, UK.

Current Pharmaceutical Design
|June 8, 2004
PubMed
Summary

Mitogen Activated Protein Kinase (MAPK) pathways are crucial for biological processes and drug discovery. This review covers MAPK signaling, drug discovery efforts, and proposes new strategies for targeting complex MAPK networks.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Strengthening translational medical research in Ireland: an interdisciplinary framework for clinician-scientist collaboration.

Irish journal of medical science·2026
Same author

Digital Twin models to address long-term treatment toxicities in children and young adults with cancer.

NPJ digital medicine·2026
Same author

Unique B- and plasma cell signature differentiates hidradenitis suppurativa from psoriasis and atopic dermatitis.

Frontiers in immunology·2026
Same author

Dual RAF inhibition outperforms RAF-MEK combinations for suppressing ERK signaling in KRAS mutant cells.

NPJ systems biology and applications·2026
Same author

Phase II Trial of Vemurafenib and Sorafenib Combination in Advanced <i>KRAS</i>-Mutated Metastatic Pancreatic Cancer.

Journal of immunotherapy and precision oncology·2026
Same author

Interrogating the immune landscape of microsatellite stable RAS-mutated colon cancer.

Molecular oncology·2026

Area of Science:

  • Biochemistry
  • Cellular Biology
  • Pharmacology

Background:

  • Mitogen Activated Protein Kinase (MAPK) pathways regulate essential biological processes.
  • These signaling cascades have become significant targets in modern drug discovery.
  • Key MAPK pathways include ERK, JNK, and p38.

Purpose of the Study:

  • To review the biochemistry and biology of MAPK signaling pathways.
  • To summarize current drug discovery efforts and clinical trials targeting MAPK pathways.
  • To critically evaluate strategies for targeting MAPK pathways and propose novel approaches.

Main Methods:

  • Literature review of MAPK pathway biochemistry and biology.
  • Analysis of current drug discovery programs and clinical trial data.

Related Experiment Videos

  • Critical discussion of existing therapeutic strategies and future directions.

    • Main Results:

    • MAPK pathways, particularly ERK, JNK, and p38, are central to numerous cellular functions.
    • Significant progress has been made in developing drugs targeting these pathways.
    • Existing strategies face challenges due to the complexity of MAPK signaling networks.

    Conclusions:

    • Targeting MAPK pathways offers therapeutic potential but requires careful consideration of network complexity.
    • Novel approaches are needed to effectively modulate MAPK signaling for drug discovery.
    • Understanding the intricate biology of MAPK pathways is key to successful therapeutic intervention.